Susie Wiles with Breast Cancer, AAP Et Al Prevails on ACIP, Look to States for Vaccine Freedom

The episode opens with the surprising announcement that Susie Wiles, President Trump’s chief of staff, is battling early‑stage breast cancer. Host Dr. Peter McCullough stresses that no evidence links the disease to COVID‑19 vaccination and proposes experimental tissue testing for spike protein, while emphasizing standard oncology treatments and the company’s botanical supplement Shield as adjuncts. This segment underscores the broader concern over attributing unrelated health issues to vaccines without rigorous data.

The conversation shifts to a federal court decision that halted Robert F. Kennedy’s vaccine‑reform lawsuit, effectively preserving the Advisory Committee on Immunization Practices (ACIP) schedule. McCullough argues that lasting vaccine‑freedom reforms must emerge from state legislation and individual choice, not a centralized federal panel. He also calls for repealing the 1986 Vaccine Injury Compensation Act’s liability shield, believing market pressure would drive safer vaccine development.

Finally, the hosts review which vaccines are mRNA‑based—currently only Pfizer and Moderna COVID shots and Moderna’s RSV candidate—and advise caution for non‑COVID uses. They promote the Wellness Company’s natural immunity regimen, including a capsule, nasal spray, and throat spray, as daily defenses against seasonal colds. The segment ties personal health practices to broader systemic reform, urging listeners to prioritize proven immunity boosters while awaiting policy changes.